Informações:
Falhas:
ID
33820
Descrição
A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01718145
Link
https://clinicaltrials.gov/show/NCT01718145
Palavras-chave
Versões (1)
- 02/01/2019 02/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
2 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C Virus Infection NCT01718145
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Chronic Hepatitis C HCV 1b
Item
chronic hcv-1b infected patient
boolean
C0524910 (UMLS CUI [1,1])
C3494965 (UMLS CUI [1,2])
C3494965 (UMLS CUI [1,2])
Hepatitis C virus RNA assay
Item
hcv ribonucleic acid (rna) > 100,000 iu/ml at screening
boolean
C1272251 (UMLS CUI [1])
Age | Cohort Therapy naive | Cohort Recurrent disease
Item
ages 20 to 70 years (for the naive cohort), ages 20 to 75 years (for the relapser cohort)
boolean
C0001779 (UMLS CUI [1])
C0599755 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0599755 (UMLS CUI [3,1])
C0277556 (UMLS CUI [3,2])
C0599755 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0599755 (UMLS CUI [3,1])
C0277556 (UMLS CUI [3,2])
Interferon therapy naive
Item
treatment naive subjects to interferon (ifn) based therapy
boolean
C0279030 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
Hepatitis C virus RNA Undetectable | Exposure to Interferon therapy | Hepatitis C virus RNA Detectable Follow-up
Item
subjects who had undetectable hcv rna at end of treatment with prior exposure to an ifn-containing regimen, but hcv rna detectable within 24 weeks of treatment follow-up
boolean
C0369335 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0279030 (UMLS CUI [2,2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C3274571 (UMLS CUI [3,3])
C3827727 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0279030 (UMLS CUI [2,2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C3274571 (UMLS CUI [3,3])
Patients Have
Item
patients who have;
boolean
C0030705 (UMLS CUI [1,1])
C3539897 (UMLS CUI [1,2])
C3539897 (UMLS CUI [1,2])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
HBV coinfection | HIV coinfection
Item
co-infection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv)
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C4062778 (UMLS CUI [2])
Severe complication | Complication Uncontrolled
Item
severe or uncontrollable complication
boolean
C3495031 (UMLS CUI [1])
C0009566 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0009566 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])